Varaico: Literature-Extracted Genetic Variants

Gene:APP
Variant:p.T714I
Back to variants list

APP

NM_000484.4:p.T714I

Associated Papers

Phenotypic variability in early-onset dementia segregating with a novel APP (p.I718M) variant.

Johansson C et al.

Alzheimer's Research & Therapy, 2025

Comparison of the ApoE allelic variants in the formation of intracerebral Aβ deposits.

Xu G et al.

Neurobiology of Disease, 2025

Cytokine-induced reprogramming of human macrophages toward Alzheimer's disease-relevant molecular and cellular phenotypes in vitro.

Podleśny-Drabiniok A et al.

Cell Reports, 2025

40570367 (PubMed )
Supplement: NIHMS2099510-supplement-6.xlsx › VSQR_THP-1

The landscape of autosomal-dominant Alzheimer's disease: global distribution and age of onset.

Liu H et al.

Brain : a Journal of Neurology, 2025

39903689 (PubMed )
Supplement: awaf038_supplementary_data.zip › 2-Supplemental_Table1_AR_20250121_JLliF.pdf

Spectrum of γ-Secretase dysfunction as a unifying predictor of ADAD age at onset across PSEN1, PSEN2 and APP causal genes.

Fernández SG et al.

Molecular Neurodegeneration, 2025

Longitudinal characterization reveals behavioral impairments in aged APP knock in mouse models.

Blackmer-Raynolds L et al.

Scientific Reports, 2025

APP substrate ectodomain defines amyloid-β peptide length by restraining γ-secretase processivity and facilitating product release.

Koch M et al.

The Embo Journal, 2023

37853914 (PubMed )
Supplement: EMBJ-42-e114372-s004.pdf

Interaction of Proteins Involved in Neuronal Proteinopathies.

Kulichikhin KY et al.

Life (basel, Switzerland), 2023

Differential and substrate-specific inhibition of γ-secretase by the C-terminal region of ApoE2, ApoE3, and ApoE4.

Hou X et al.

Neuron, 2023

Specific Mutations near the Amyloid Precursor Protein Cleavage Site Increase γ-Secretase Sensitivity and Modulate Amyloid-β Production.

Suzuki R et al.

International Journal of Molecular Sciences, 2023

Rare Amyloid Precursor Protein Point Mutations Recapitulate Worldwide Migration and Admixture in Healthy Individuals: Implications for the Study of Neurodegeneration.

Abondio P et al.

International Journal of Molecular Sciences, 2022

36555510 (PubMed )
Supplement: ijms-23-15871-s001.zip › ijms-2049902-supplementary.xlsx › S1

Structural Determinant of β-Amyloid Formation: From Transmembrane Protein Dimerization to β-Amyloid Aggregates.

Papadopoulos N et al.

Biomedicines, 2022

Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia.

Xia D et al.

Molecular Neurodegeneration, 2022

Clinical characteristics and genotype-phenotype correlation analysis of familial Alzheimer's disease patients with pathogenic/likely pathogenic amyloid protein precursor mutations.

Liu Y et al.

Frontiers in Aging Neuroscience, 2022

Conformational Models of APP Processing by Gamma Secretase Based on Analysis of Pathogenic Mutations.

Kim M et al.

International Journal of Molecular Sciences, 2021

Cerebral Small Vessel Disease in Sporadic and Familial Alzheimer Disease.

Kalaria RN et al.

The American Journal of Pathology, 2021

Mechanisms of neurodegeneration - Insights from familial Alzheimer's disease.

Chávez-Gutiérrez L et al.

Seminars in Cell & Developmental Biology, 2020

New Insights into the Molecular Bases of Familial Alzheimer's Disease.

D'Argenio V et al.

Journal of Personalized Medicine, 2020

The protective mutation A673T in amyloid precursor protein gene decreases Aβ peptides production for 14 forms of Familial Alzheimer's Disease in SH-SY5Y cells.

Guyon A et al.

Plos One, 2020

UniProt genomic mapping for deciphering functional effects of missense variants.

McGarvey PB et al.

Human Mutation, 2019

30840782 (PubMed )
Supplement: HUMU-40-694-s001.docx

Processing of Mutant β-Amyloid Precursor Protein and the Clinicopathological Features of Familial Alzheimer's Disease.

Bi C et al.

Aging and Disease, 2019

Genetic Markers of Alzheimer's Disease.

Nikolac Perkovic M et al.

Advances in Experimental Medicine and Biology, 2019

Somatic APP gene recombination in Alzheimer's disease and normal neurons.

Lee MH et al.

Nature, 2018

The genes associated with early-onset Alzheimer's disease.

Dai MH et al.

Oncotarget, 2018

Clinical aspects and biomarkers of Alzheimer's disease in Down syndrome.

Zis P et al.

Free Radical Biology & Medicine, 2018

Alzheimer's-Causing Mutations Shift Aβ Length by Destabilizing γ-Secretase-Aβn Interactions.

Szaruga M et al.

Cell, 2017

Genetics of β-Amyloid Precursor Protein in Alzheimer's Disease.

Tcw J et al.

Cold Spring Harbor Perspectives in Medicine, 2017

APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.

Lanoiselée HM et al.

Plos Medicine, 2017

28350801 (PubMed )
Supplement: pmed.1002270.s001.xlsx › APP_mutations

Comprehensive Screening for Disease Risk Variants in Early-Onset Alzheimer's Disease Genes in African Americans Identifies Novel PSEN Variants.

N'Songo A et al.

Journal of Alzheimer's Disease : Jad, 2017

Alzheimer's Disease: From Genetic Variants to the Distinct Pathological Mechanisms.

Sun Q et al.

Frontiers in Molecular Neuroscience, 2017

One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina.

Gupta V et al.

Cellular and Molecular Life Sciences : Cmls, 2016

Genomics of Alzheimer Disease: A Review.

Rosenberg RN et al.

Jama Neurology, 2016

A systematic review of familial Alzheimer's disease: Differences in presentation of clinical features among three mutated genes and potential ethnic differences.

Shea YF et al.

Journal of the Formosan Medical Association = Taiwan Yi Zhi, 2016

Alzheimer's disease-associated mutations increase amyloid precursor protein resistance to γ-secretase cleavage and the Aβ42/Aβ40 ratio.

Xu TH et al.

Cell Discovery, 2016

27625790 (PubMed )
Supplement: celldisc201626-s1.pdf

Role of Apolipoprotein E in β-Amyloidogenesis: ISOFORM-SPECIFIC EFFECTS ON PROTOFIBRIL TO FIBRIL CONVERSION OF Aβ IN VITRO AND BRAIN Aβ DEPOSITION IN VIVO.

Hori Y et al.

The Journal of Biological Chemistry, 2015

Homozygous carriers of APP A713T mutation in an autosomal dominant Alzheimer disease family.

Conidi ME et al.

Neurology, 2015

Unfolded Protein Response and PERK Kinase as a New Therapeutic Target in the Pathogenesis of Alzheimer's Disease.

Rozpedek W et al.

Current Medicinal Chemistry, 2015

Abundance of Aβ₅-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease.

Guzmán EA et al.

Molecular Neurodegeneration, 2014

Characterization of intermediate steps in amyloid beta (Aβ) production under near-native conditions.

Olsson F et al.

The Journal of Biological Chemistry, 2014

Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production.

Suárez-Calvet M et al.

Journal of Neurochemistry, 2014

Early onset Alzheimer's disease and oxidative stress.

Meraz-Ríos MA et al.

Oxidative Medicine and Cellular Longevity, 2014

The genetics of Alzheimer's disease.

Bagyinszky E et al.

Clinical Interventions in Aging, 2014

Amyloid β in hereditary cerebral hemorrhage with amyloidosis-Dutch type.

Kamp JA et al.

Reviews in the Neurosciences, 2014

1–50 of 85 papers
Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."